Procalcitonin in Pleural Pleuritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01011881
Recruitment Status : Completed
First Posted : November 11, 2009
Last Update Posted : June 9, 2016
Information provided by (Responsible Party):
Centre Hospitalier Universitaire, Amiens

Brief Summary:
The purpose of this study is to determine pleural level of procalcitonin in differents situations of pleuritis.

Condition or disease Intervention/treatment
Pleuritis Pleural Empyema Other: pleural level of procalcitonin

Detailed Description:

Determine pleural level of procalcitonin in pleuritis. Two periods First period evaluation in vitro study/ Determine adequat technique included type of samples tubes for adequat analysis.

Second periods : Patient with pleuritis . Empyema or not

Study Type : Observational
Actual Enrollment : 34 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation de la Mesure du Taux de la Procalcitonine Dans Les Liquides Pleuraux
Study Start Date : October 2009
Actual Primary Completion Date : February 2011
Actual Study Completion Date : February 2011

Group/Cohort Intervention/treatment
patients with pleuritis Other: pleural level of procalcitonin
no intervention

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 99 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with pleuritis

Inclusion Criteria:

  • Pleuritis
  • Hospitalisation

Exclusion Criteria:

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01011881

CHU Amiens
Amiens, France, 80000
Sponsors and Collaborators
Centre Hospitalier Universitaire, Amiens

Responsible Party: Centre Hospitalier Universitaire, Amiens Identifier: NCT01011881     History of Changes
Other Study ID Numbers: PI09-DR-DOUADI
First Posted: November 11, 2009    Key Record Dates
Last Update Posted: June 9, 2016
Last Verified: June 2016

Keywords provided by Centre Hospitalier Universitaire, Amiens:

Additional relevant MeSH terms:
Empyema, Pleural
Pathologic Processes
Pleural Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Bone Density Conservation Agents
Physiological Effects of Drugs